Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine.

Transplant international : official journal of the European Society for Organ Transplantation - 1 Jan 1999

Meisel H, Preikschat P, Reinke P, Hocher B, Budde K, Bechstein W O, Neuhaus P, Krüger D H, Neumayer H H

Abstract excerpt

Hepatitis B virus (HBV) core deletion variants with enhanced viral replication are associated with rapid deterioration of liver function in renal allograft recipients. Antiviral agents such as famciclovir and lamivudine offer new treatment strategies for these patients. Appearance, accumulation and persistence of HBV core deletion mutants were closely monitored in a kidney transplant recipient with liver...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 2-Aminopurine
Share to Hepatitis B Core Antigens

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis B Surface Antigens

Share to Immunosuppressive Agents

Share to Kidney Transplantation

Share to Lamivudine

Share to Liver Transplantation

Share to Renal Dialysis

Source

Identifiers

PMID: 10460876
DOI: 10.1007/s001470050225

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine.PMID 10460876Read ↗

The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.Semantic proximity Read ↗

Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients.Semantic proximity Read ↗

Fibrosing cholestatic hepatitis in a renal transplant recipient associated with the hepatitis B virus precore mutant.Semantic proximity Read ↗

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.Semantic proximity Read ↗

Clinical impact of the development of YMDD mutants in hepatitis B virus-associated glomerulonephritis.Semantic proximity Read ↗

Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.Semantic proximity Read ↗

Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine.Semantic proximity Read ↗

Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.Semantic proximity Read ↗

Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation.Semantic proximity Read ↗

Fatal liver failure with the emergence of hepatitis B surface antigen variants with multiple stop mutations after discontinuation of lamivudine therapy.Semantic proximity Read ↗

Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.